Impaired signaling via the high-affinity IgE receptor in Wiskott-Aldrich syndrome protein-deficient mast cells.

Wiskott-Aldrich syndrome protein (WASP) is the product of the gene deficient in boys with X-linked Wiskott-Aldrich syndrome. We assessed the role of WASP in signaling through the high-affinity IgE receptor (FcepsilonRI) using WASP-deficient mice. IgE-dependent degranulation and cytokine secretion were markedly diminished in bone marrow-derived mast cells from WASP-deficient mice. Upstream signaling events that include FcepsilonRI-triggered total protein tyrosine phosphorylation, and protein tyrosine phosphorylation of FcepsilonRIbeta and Syk were not affected by WASP deficiency. However, tyrosine phosphorylation of phospholipase Cgamma and Ca(2+) mobilization were diminished. IgE-dependent activation of c-Jun N-terminal kinase, cell spreading and redistribution of cellular F-actin in mast cells were reduced in the absence of WASP. We conclude that WASP regulates FcepsilonRI-mediated granule exocytosis, cytokine production and cytoskeletal changes in mast cells.

[1]  J. Hartwig,et al.  WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. , 2002, Immunity.

[2]  S. Grinstein,et al.  Evidence for a molecular complex consisting of Fyb/SLAP, SLP-76, Nck, VASP and WASP that links the actin cytoskeleton to Fcgamma receptor signalling during phagocytosis. , 2001, Journal of cell science.

[3]  J. Rivera,et al.  Vav1 Regulates Phospholipase Cγ Activation and Calcium Responses in Mast Cells , 2001, Molecular and Cellular Biology.

[4]  L. Samelson,et al.  Dynamic actin polymerization drives T cell receptor-induced spreading: a role for the signal transduction adaptor LAT. , 2001, Immunity.

[5]  L. Samelson,et al.  LAT Is Essential for FcεRI-Mediated Mast Cell Activation , 2000 .

[6]  James S. Song,et al.  The Src Homology 2 Domain of Vav Is Required for Its Compartmentation to the Plasma Membrane and Activation of C-Jun Nh2-Terminal Kinase 1 , 2000, The Journal of experimental medicine.

[7]  K. Siminovitch,et al.  Antigen Receptor–Induced Activation and Cytoskeletal Rearrangement Are Impaired in Wiskott-Aldrich Syndrome Protein–Deficient Lymphocytes , 1999, The Journal of experimental medicine.

[8]  T. Tan,et al.  Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway. , 1999, Journal of immunology.

[9]  R. Geha,et al.  SLP-76 deficiency impairs signaling via the high-affinity IgE receptor in mast cells. , 1999, The Journal of clinical investigation.

[10]  R. Seger,et al.  The Cytoskeletal Network Controls c-Jun Expression and Glucocorticoid Receptor Transcriptional Activity in an Antagonistic and Cell-Type-Specific Manner , 1999, Molecular and Cellular Biology.

[11]  T. Ishizuka,et al.  Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. , 1999, Journal of immunology.

[12]  Laura M. Machesky,et al.  Scar1 and the related Wiskott–Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex , 1998, Current Biology.

[13]  B. Mayer,et al.  Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76. , 1998, Immunity.

[14]  A. Abo Understanding the molecular basis of Wiskott-Aldrich syndrome , 1998, Cellular and Molecular Life Sciences CMLS.

[15]  P. Chavrier,et al.  Tyrosine phosphorylation of the Wiskott‐Aldrich Syndrome protein by Lyn and Btk is regulated by CDC42 , 1998, FEBS letters.

[16]  R. Geha,et al.  The Wiskott-Aldrich Syndrome Protein-interacting Protein (WIP) Binds to the Adaptor Protein Nck* , 1998, The Journal of Biological Chemistry.

[17]  Philip R. Cohen,et al.  Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. , 1998, Immunity.

[18]  F. Alt,et al.  Involvement of Bruton's Tyrosine Kinase in FcεRI-dependent Mast Cell Degranulation and Cytokine Production , 1998, The Journal of experimental medicine.

[19]  J. Downward Mechanisms and consequences of activation of protein kinase B/Akt. , 1998, Current opinion in cell biology.

[20]  T. Baumruker,et al.  Common and distinct signaling pathways mediate the induction of TNF-alpha and IL-5 in IgE plus antigen-stimulated mast cells. , 1998, Journal of immunology.

[21]  T. Kawakami,et al.  Early and late events in Fc epsilon RI signal transduction in human cultured mast cells. , 1997, Journal of immunology.

[22]  S. Galli,et al.  IgE Enhances Mouse Mast Cell FcεRI Expression In Vitro and In Vivo: Evidence for a Novel Amplification Mechanism in IgE-dependent Reactions , 1997, The Journal of Experimental Medicine.

[23]  M. Turner,et al.  Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. , 1996, Oncogene.

[24]  J. Rivera,et al.  Association of a p95 Vav-containing signaling complex with the FcepsilonRI gamma chain in the RBL-2H3 mast cell line. Evidence for a constitutive in vivo association of Vav with Grb2, Raf-1, and ERK2 in an active complex. , 1996, The Journal of biological chemistry.

[25]  J. Kinet,et al.  IgE receptor (Fc epsilon RI) and signal transduction. , 1996, The European respiratory journal. Supplement.

[26]  T. Ishizuka,et al.  Aggregation of the FcepsilonRI on mast cells stimulates c-Jun amino-terminal kinase activity. A response inhibited by wortmannin. , 1996, The Journal of biological chemistry.

[27]  J. Bolen,et al.  Temporal Activation of Nontransmembrane Protein-tyrosine Kinases following Mast Cell FcεRI Engagement (*) , 1995, The Journal of Biological Chemistry.

[28]  A. Liu,et al.  ISOLATION OF A NOVEL GENE MUTATED IN WISKOTT-ALDRICH SYNDROME , 1995, Pediatrics.

[29]  F. Santini,et al.  Activation of the mitogen-activated protein kinase/cytosolic phospholipase A2 pathway in a rat mast cell line. Indications of different pathways for release of arachidonic acid and secretory granules. , 1995, Journal of immunology.

[30]  G. Roberto Burgio,et al.  The Wiskott-Aldrich syndrome , 1995, European Journal of Pediatrics.

[31]  P. Leder,et al.  Active anaphylaxis in IgE-deficient mice , 1994, Nature.

[32]  J. Norman,et al.  Actin filament organization in activated mast cells is regulated by heterotrimeric and small GTP-binding proteins , 1994, The Journal of cell biology.

[33]  F. Rendu,et al.  Calcium mobilisation controls tyrosine protein phosphorylation independently of the activation of protein kinase C in human platelets , 1994, FEBS letters.

[34]  D. Dombrowicz,et al.  Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene , 1993, Cell.

[35]  C. Terhorst,et al.  T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. , 1993, Journal of immunology.

[36]  S. Galli,et al.  Effects of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. Genetically mast cell-deficient Sl/Sld mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses. , 1993, The Journal of clinical investigation.

[37]  G K Lewis,et al.  Actin polymerization and pseudopod reorganization accompany anti-CD3-induced growth arrest in Jurkat T cells. , 1993, Journal of immunology.

[38]  J. Drazen,et al.  Mast cells contribute to the changes in heart rate, but not hypotension or death, associated with active anaphylaxis in mice. , 1993, Journal of immunology.

[39]  A. Ullrich,et al.  Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs , 1992, Nature.

[40]  L. Frigeri,et al.  Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. , 1992, Journal of immunology.

[41]  S. Rhee,et al.  IgE-induced tyrosine phosphorylation of phospholipase C-gamma 1 in rat basophilic leukemia cells. , 1991, The Journal of biological chemistry.

[42]  S. Galli,et al.  Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses. , 1991, The Journal of clinical investigation.

[43]  M. Tsai,et al.  The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype , 1991, The Journal of experimental medicine.

[44]  K. Austen,et al.  Recent advances in the cellular and molecular biology of mast cells. , 1989, Immunology today.

[45]  W. Paul,et al.  Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores , 1989, Nature.

[46]  D. Seldin,et al.  Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. , 1984, Journal of immunology.

[47]  L. Samelson,et al.  LAT is essential for Fc(epsilon)RI-mediated mast cell activation. , 2000, Immunity.

[48]  T. Ishizuka,et al.  Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. , 1999, Journal of immunology.

[49]  J. Bolen,et al.  Temporal activation of nontransmembrane protein-tyrosine kinases following mast cell Fc epsilon RI engagement. , 1995, The Journal of biological chemistry.